Peter Ellis, 69, from Manchester tells us about his experience finding out he had prostate cancer after an unlucky golf ...

In the UK, most prostate cancers are diagnosed in men aged 75–79, but rates rise steeply from 45–49. Black men are also more ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

A CHARITY has called for men at high risk of developing prostate cancer to be screened from the age of 45. It comes after Sir ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of ...